Atezolizumab + Cabozantinib Postpones mCRPC Progression.

Published Date: 29 Jan 2024

Comparing combination to more hormonal therapy, PFS was improved, but the control arm was questioned.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pollution exposure may affect lung cancer in women who have never smoked

2.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

3.

Approved BTK Inhibitor Without Covalent Bond for CLL.

4.

Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.

5.

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot